BCL2L1 and acute lymphoblastic leukemia: CD49d (α4:β1) has been shown to predict overall survival in CLL and is involved in chemo-resistance in ALL and AML; in CLL, it contributes to fludarabine resistance by inducing Bcl-xL overexpression and inhibiting apoptosis [21,23,24,25].